Search Results - "Fatehi, Samuel"

G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease by Signoretti, Christina, Matsumura, Shun, Fatehi, Samuel, D'Silva, Melinee, Mathew, Rajamma, Cendali, Francesca, D'Alessandro, Angelo, Alam, S M Shafiqul, Garcia, Victor, Miano, Joseph M, Gupte, Sachin A

“…G6PD (glucose-6-phosphate-dehydrogenase) is a key enzyme in the glycolytic pathway and has been implicated in the pathogenesis of cancer and pulmonary…”
Get full text

Insight into the increased risk associated with CRISPR-generated African G6PD variant (N126D) in rat model of sugen-5416-induced pulmonary hypertension by Signoretti, Christina, Matsumura, Shun, Fatehi, Samuel, Gupte, Sachin

“…Abstract only Pulmonary Hypertension (PH) is a cardiopulmonary disease associated with sustained increase in pulmonary arterial and right ventricular…”
Get full text

Loss-of-function G6PD variant moderated high-fat diet-induced obesity, adipocyte hypertrophy, and fatty liver in male rats by Matsumura, Shun, Signoretti, Christina, Fatehi, Samuel, Tumenbayar, Bat Ider, D’Addario, Catherine, Nimmer, Erik, Thomas, Colin, Viswanathan, Trisha, Wolf, Alexandra, Garcia, Victor, Rocic, Petra, Bae, Yongho, Alam, SM Shafiqul, Gupte, Sachin A.

“…Obesity is a major risk factor for liver and cardiovascular diseases. However, obesity-driven mechanisms that contribute to the pathogenesis of multiple organ…”
Get full text

G6pd N126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease by Signoretti, Christina, Matsumura, Shun, Fatehi, Samuel, D'Silva, Melinee, Mathew, Rajamma, Cendali, Francesca, D'Alessandro, Angelo, Alam, S M Shafiqul, Garcia, Victor, Miano, Joseph M, Gupte, Sachin A

“…G6PD (glucose-6-phosphate-dehydrogenase) is a key enzyme in the glycolytic pathway and has been implicated in the pathogenesis of cancer and pulmonary…”
Get full text